🇺🇸 FDA
Pipeline program

Lurbinectedin

23872

Phase 2 small_molecule terminated

Quick answer

Lurbinectedin for Locally Advanced Soft Tissue Sarcoma is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Locally Advanced Soft Tissue Sarcoma
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials